MI risk is best captured by number of apoB-containing lipoproteins
This video was recorded in response to a recent publication in JAMA Cardiology by Marston and colleagues.
Nicolas Marston is affiliated with the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: